Tag Archives: pharmaceutical

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Much like many animals

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

Take a look at the slide below and see if you can answer which of the 5 drugs had a peak sales year of $13.7 billion. The answer? – Lipitor While Lipitor sold a gigantic $13.7 billion in their peak sales year,

Can Sovaldi’s Launch Success Be Repeated? Examining How Gilead Sciences Utilized Marketing Mix To Rewrite Launch History

We all know this story: Ninety-five percent of drugs in the development pipeline fail to clear the safety and efficacy profiles, and companies then add that R&D cost of such failures to the price of the drug that does reach the

Overcoming Regulatory Risks and Gaining Critical Insights through Social Media Listening

The pharmaceutical industry as a whole has struggled to delve into the social media world. The main reason for this is due to regulatory restrictions, with organizations fearful to engage in online conversations with patients due to the perceived high

Seven Important Steps to Seamless Pharmaceutical Advisory Board Management

Pharmaceutical and medical device companies seeking guidance on clinical trials, marketing campaigns assessment, or product reimbursement strategies turn towards the expertise provided by key advisory boards. However, managing successful advisory boards today comes at a cost, which can be anywhere

Best Practices Hosting 6th Medical Affairs Consortium on HEOR

Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable

As Mobile Surpasses Desktop Search, Poll of Digital Marketers Finds Industry Divided on Pharma’s Next Steps

In a digital advertising conference yesterday, Google announced that mobile searches have surpassed desktop searches in the U.S. and numerous other countries. This is big news, but a not necessarily stunning development to anyone paying close attention to the inexorable

One Way to Please the Boss (& the Boss’s Boss): Crafting Highly Effective Executive Briefs

A quick peek behind the curtain at the Best Practices Research Center and a Most Interesting Case that recently landed on my desk. We are a consulting firm whose clients work mainly in the pharma and biotech sector.  As a

Patient Centricity Has Arrived. Bigger Question: Where Is It Headed?

Patients have always been on pharma’s radar, though it has historically been as a target of marketing (the most obvious being Direct to Consumer (DTC) advertising).  But now under the banner of Patient Centricity, pharma companies large and small are

Six Digital Marketing Trends that will Affect the Pharmaceutical Industry in 2015

The pharma sector has long trailed more consumer and tech-savvy industries in the uptake of digital media for marketing their products. Uncertainty around industry regulations and how to safely interact with patients and physicians have prevented many large pharma organizations

Internal Communication Commandments to Live By

In order to improve an organization as a whole, it is critical to improve internal corporate communications. Best Practices, LLC’s work highlights how companies deliver their internal messages and find the proper balance between informing and educating employees. We have seen companies

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from

5 Things Pharma Professionals Need to Know About Big Data

Big Data has its roots in a set of statistical methods called econometrics A main feature of the finance, biology, and the social sciences is the apparent randomness of the behaviors being measured. Econometrics exists to distill the random and

Big Data in Pharma: What is Big Data?

We are past the peak of the Big Data hypecycle, not least of all because about half of the content on the topic put out by marketing gurus, branding experts, and other non-practitioners has moved on from extolling Big Data